Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials - Young, JB; Dunlap, ME; Pfeffer, MA (Circulation, 2004)
et al.